The Life Sciences in New York State

Tough day for our neighbors in CT

I wonder if Pfizer is hiring?

Bayer to close Connecticut research operation as part of global reorganization

WEST HAVEN, Connecticut: Bayer HealthCare plans to close its research operation in West Haven by early 2008 as part of a larger worldwide reorganization and consolidation, the company said Thursday.

Rochester-based iCardiac Series A is oversubscribed

Congratulations! Further proof that good technology can attract venture funding, irrespective of geographic location.

iCardiac Technologies Completes Oversubscribed Series A Round

ROCHESTER, N.Y., Nov. 7-- iCardiac Technologies, Inc., a company formed earlier this year to commercialize leading cardiac safety technologies developed at the University of Rochester Medical Center, announced today that it has completed its Series A offering with an additional investment of $2 million. This investment, led by the national venture capital firms of Advantage Capital Partners and Stonehenge Capital Company, brings the total Series A investment to $4 million.

New Relationship with European PE Shop

Today I officially joined ARW Business House as an "Ambassador," which is a much fancier title that Associate. It's not a full time job. I'm not giving up my consulting and other initiatives. But, the relationship with ARW allows me to bring a whole suite of transactional capabilities to my life science clients.

The ARW private equity practice is focused on investing in revenue-generating "anchor" companies who seek to grow via merger and acquisition. This growth may be through the acquisition of suppliers, customers, and/or competitors. The practice is global in scope. Transactions of any substantial size (preferably >EURO 50 million) would be considered.

So, if you think you would like to grow via M&A, I might be able to help you. MBOs, MBIs, and LBOs are also actively sought. Feel free to send me a note or call on Skype.